Bureau Veritas (BVI) Q3 2024 TU earnings summary

Executive summary

• Q3 2024 revenue reached €1,555 million, up 8.8% year-over-year, with 13% organic growth and all business lines and regions contributing; Americas and Africa/Middle East led with 18.3% and 23.4% organic growth, respectively.

• The company upgraded its 2024 revenue outlook for the second time, now expecting 9–10% organic growth, improved adjusted operating margin, and cash conversion above 90%.

• Portfolio refocused through seven acquisitions (€80 million annualized revenue) and two divestments (€165 million annualized revenue), including the sale of the Food testing business.

• Accelerated execution of the LEAP | 28 strategy, focusing on organic growth, sustainability, and active portfolio management.

• Strong financial position with €1.2 billion in cash, €600 million in undrawn credit lines, and most debt maturing after 2026 at fixed rates.

Financial highlights

• Q3 2024 revenue rose 8.8% year-over-year to €1,547.9 million; organic growth was 13.0%, with a -4.7% currency impact and 0.5% scope effect.

• Nine-month 2024 revenue totaled €4,569.6 million, with 10.5% organic growth and a -5.1% currency impact.

• Recent acquisitions contributed 1.1% to revenue, while divestments offset some gains.

• Net financial debt increased sequentially due to dividend payments.

Outlook and guidance

• Full-year 2024 organic revenue growth is now expected in the 9–10% range, up from previous high single-digit guidance.

• Adjusted operating margin is expected to improve at constant currency, with cash conversion above 90%.

• Mid- to high-single-digit organic growth is targeted for 2024–2028.